Status: This project is in progress

AHRQ diabetes decision aid for patients and pharmacistsThe Canadian Diabetes Association estimates that diabetes costs the Canadian healthcare system and economy some $11.7 billion annually.

Supporting diabetes management is essential for patients living with this chronic disease. Governments have recognized this and in 2011 Ontario’s Ministry of Health and Long-Term Care expanded its MedsCheck Program to provide patients with Type 1 or 2 diabetes. This expansion in scope of practice provided Ontario’s provincial drug plan beneficiaries with the opportunity to receive medication reviews and diabetes education from community pharmacists.

Shared decision-making and patient-centred care are critical components of healthcare. Shared decision-making focused originally on the physician-patient relationship, but such decision-making is increasingly being applied to other clinician-patient interactions. Despite its potential, little literature has been published on the application of shared decision-making models within other clinical areas.

The use of decision aids and shared decision-making tools by patients promotes their involvement in decisions, increasing knowledge of their disease, decreasing decisional conflict, and improving satisfaction and health outcomes. Although diabetes management decision aids exist, the majority of them have been developed for use by patients with their physicians.

The Mayo Clinic has developed a suite of decision-making tools for use by physicians and patients during office visits. A scan of the literature suggests that no patient-informed decision aid exists at the patient-pharmacist point of care, even though pharmacists are well placed to engage in discussions that can promote shared decision-making.

Pharmacists across Canada including many in Ontario have indicated a strong desire for more diabetes education, including tools and processes that can help them work with patents to improve drug therapy decision-making.

Research questions
  1. What are the barriers and facilitators to community pharmacists implementing an adapted Mayo Clinic tool for decision-making and education related to diabetes medication education?
  2. What adaptations should be made to the Mayo Clinic shared decision-making tool for diabetes medication?

Project researchers will fill these knowledge gaps by adapting the Mayo Clinic decision-making tools for diabetes medication to create a patient-informed decision aid to be used by Ontario patients with their community pharmacists during diabetes management consultations.

Primary knowledge user: Lori MacCallum, Program Director, Knowledge Translation and Optimizing Care Models, Banting and Best Diabetes Centre

Project lead: Zahava Rosenberg-Yunger

For more information about this applied health research question, please contact Annie Lok, AHRQ administrator.